| 摘要 |
Disclosed are compounds of the formula (1). and the pharmaceutically acceptable salts thereof. X is N or N+O-, and Y is N or N+O-, provided that at least X or Y is N. The compounds are useful for the treatment of chemokine- mediated diseases such as COPD.
|
